Gujarat: 42.24 Lakh Tramadol Tablets Seized Worth Rs 70 Crores

Kachchh: Large shipments consisting of tablets of Tramadol have been seized by the Special Investigation and Intelligence Branch (SIIB) of Mundra Customs. 68,00,000 tablets of Tramadol have been seized, as per SIIB Mundra Customs. Total value of seized tablets is estimated to be around Rs 110 crores – based on International Street Value.

One of the shipments consisted of Tramaking and the other consisted of Royal-225 tablets. Both were destined for the African country of Sierra Leone.

Tramadol was notified as the psychotropic substance under NDPS Act in 2018, SIIB Mundra Customs said.

In recent times, Tramadol has been used by fighters in war torn areas in countries in the Middle East, Asia, and west Africa.

The present consignments, which were intercepted, were destined for Sierra Leone. The first shipment consisted of Tramaking 225 (Tramadol Hydrochloride Tablet 225 mg). The second shipment consisted of Royal-225 (Tramadol Hydrochloride Tablet 225 mg) and was seized in a warehouse.

The first shipment consisted of 26,26,000 tablets and was valued at Rs 40 crores. It was seized on July 27. The second shipment consisted of 42,24,000 tablets, valued at Rs 70 crores, and was seized the next day on July 28.

“Based on intelligence gathered by SIIB Mundra, one export consignment of a merchant exporter destined for Sierra Leone with declared description as Diclofenac Tab and Gebedol Tab was intercepted and examined,” SIIB Mundra Customs said.

Tramadol “is a psychotropic substance and export of tramadol is restricted under section 8(c) of NDPS Act, 1985. Follow-up searches are underway at Rajkot, Gandhinagar and Gandhidham,” they added. While the present shipments were destined for Sierra Leone, SIIB Mundra Customs said that the drug is also in high demand in African countries.

“Tramadol has gained notoriety in recent times after it was reported that ISIS fighters used it to stay awake for long hours. It is also reported that this synthetic opioid drug is popular and in high demand in African nations like Nigeria, Ghana, etc.”

Further investigation into the matter is currently underway, they said.

Related Posts

Nearly Three in Ten Products in Indian Local Markets Perceived as Counterfeit; Pharmaceuticals and FMCG among Worst-Affected Sectors: ASPA–CRISIL Intelligence Report

New Delhi: Nearly 29% of products available in India’s local markets are perceived by consumers to be counterfeit, highlighting the growing challenge of fake goods across critical sectors, including pharmaceuticals…

Culture reports reveal bacteria damaged cornea of five patients from Kuchaman

Jaipur: Culture reports confirmed that five patients shifted to SMS Hospital, Jaipur, after cataract surgery at Kuchaman govt hospital have tested positive for serious postoperative eye infections caused by Enterobacter…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Nearly Three in Ten Products in Indian Local Markets Perceived as Counterfeit; Pharmaceuticals and FMCG among Worst-Affected Sectors: ASPA–CRISIL Intelligence Report

Nearly Three in Ten Products in Indian Local Markets Perceived as Counterfeit; Pharmaceuticals and FMCG among Worst-Affected Sectors: ASPA–CRISIL Intelligence Report

Culture reports reveal bacteria damaged cornea of five patients from Kuchaman

Culture reports reveal bacteria damaged cornea of five patients from Kuchaman

FSSAI prohibits Dabur from selling food products with ‘100%’ claims

FSSAI prohibits Dabur from selling food products with ‘100%’ claims

ORSL reinforces its commitment to improve diarrhoeal prevention in children

ORSL reinforces its commitment to improve diarrhoeal prevention in children

‘Donors got mixer grinders, cash’: blood banks in Bengal under scanner over ‘illegal’ sale to other States

‘Donors got mixer grinders, cash’: blood banks in Bengal under scanner over ‘illegal’ sale to other States

CREATE Medicines expands targeted in vivo CAR platform through strategic research collaboration and exclusive license pact with Monash University

CREATE Medicines expands targeted in vivo CAR platform through strategic research collaboration and exclusive license pact with Monash University